Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells

Neoplasma

Volumn 58, Issue 5, 2011, Pages 361-370

  Kucerova, L ^a   Kovacovicova, M ^b   Polak, S ^b   Bohac, M ^c   Fedeles, J ^c   Palencar, D ^c   Matuskova, M ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Adipose tissue; Breast cancer; Cytokine profile; Human mesenchymal stromal cells; Proliferation

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; MESSENGER RNA; TUMOR MARKER;

ADIPOSE TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STROMA CELL; PROTEIN EXPRESSION; TARGET CELL; BREAST TUMOR; CULTURE MEDIUM; CYTOLOGY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR CELL CULTURE;

ADIPOSE TISSUE; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMOKINES; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MESENCHYMAL STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 80052148576     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_05_361     Document Type: Article

References (51)

1. PULAGAM SR, POULTON T, MAMOUNAS EP. Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature. Breast J 2006; 12: 63-65. doi:10.1111/j.1075-122X.2006.00188.x
2. FEHM T, MUELLER V, MARCHES R, KLEIN G, GUECKEL B et al. Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS 2008; 116: 742-753. doi:10.1111/j.1600-0463.2008.01047.x
3. MISSANA MC, LAURENT I, BARREAU L, BALLEYGUIER C. et al. Autologous fat transfer in reconstructive breast surgery: indications, technique and results. Eur J Surg Oncol 2007; 33: 685-690. doi:10.1016/j.ejso.2006.12.002
4. COLEMAN SR, SABOEIRO AP. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007; 119: 775-785; discussion 786-787. doi:10.1097/01.prs.0000252001.59162.c9
5. SPEAR SL, NEWMAN MK, BEDFORD MS, SCHWARTZ KA, COHEN M, SCHWARTZ JS. A retrospective analysis of outcomes using three common methods for immediate breast reconstruction. Plast Reconstr Surg 2008; 122: 340-347. doi:10.1097/PRS.0b013e31817d6009
6. Report on autologous fat transplantation. ASPRS Ad-Hoc Committee on New Procedures, September 30, 1987. Plast Surg Nurs 1987; 7: 140-141.
7. SNYDERMAN RK. Breast cancer and fat transplants. Plast Reconstr Surg 1988; 81: 991. doi:10.1097/00006534-198806000-00052
8. YOSHIMURA K, SATO K, AOI N, KURITA M, HIROHI T, HARII K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008; 32: 48-55; discussion 56-57. doi:10.1007/s00266-007-9019-4
9. DELAY E, DELPIERRE J, SINNA R, CHEKAROUA K [How to improve breast implant reconstructions?]. Ann Chir Plast Esthet 2005; 50: 582-594. doi:10.1016/j.anplas.2005.08.008
10. BOBIN JY, DELAY E [Plastic surgery and breast cancer. Are there contraindications for plastic surgery?]. Ann Chir Plast Esthet 1992; 37: 673-681.
11. ZHAO M, DUMUR CI, HOLT SE, BECKMAN MJ, ELMORE LW. Multipotent adipose stromal cells and breast cancer development: Think globally, act locally. Mol Carcinog 2010; 49: 923-927. doi:10.1002/mc.20675
12. NELSON CM, BISSELL MJ. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006; 22: 287-309. doi:10.1146/annurev.cellbio.22.010305.104315
13. DITTMER J. Mesenchymal stem cells: "repair cells that serve wounds and cancer? ScientificWorld Journal 2010; 10: 1234-1238.
14. BROOKE G, COOK M, BLAIR C, HAN R, HEAZLEWOOD C et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 2007; 18: 846-858. doi:10.1016/j.semcdb.2007.09.012
15. KIDD S, SPAETH E, KLOPP A, ANDREEFF M, HALL B, MARINI FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 2008; 10: 657-667. doi:10.1080/14653240802486517
16. Dwyer RM, Potter-Beirne SM, HARRINGTON KA, LOWERY AJ, HENNESSY E et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007; 13:5020-5027. doi:10.1158/1078-0432.CCR-07-0731
17. LIN SY, YANG J, EVERETT AD, CLEVENGER CV, KONERU M et al. The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res 2008; 314: 3107-3117. doi:10.1016/j.yexcr.2008.07.028
18. MISHRA PJ, MISHRA PJ, HUMENIUK R, MEDINA DJ, ALEXE G et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68: 4331-4339. doi:10.1158/0008-5472.CAN-08-0943
19. SCHAFFLER A, BUCHLER C. Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818-827. doi:10.1634/stemcells.2006-0589
20. MANABE Y, TODA S, MIYAZAKI K, SUGIHARA H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003; 201: 221-228. doi:10.1002/path.1430
21. YU JM, JUN ES, BAE YC, JUNG JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008; 17: 463-473. doi:10.1089/scd.2007.0181
22. IYENGAR P, COMBS TP, Shah SJ, Gouon-Evans V, POLLARD JW, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003; 22: 6408-6423. doi:10.1038/sj.onc.1206737
23. WALTER M, LIANG S, GHOSH S, HORNSBY PJ, LI R. Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 2009; 28: 2745-2755. doi:10.1038/onc.2009.130
24. PINILLA S, ALT E, ABDUL KHALEK FJ, JOTZU C, MUEHLBERG F et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 2009; 284: 80-85. doi:10.1016/j.canlet.2009.04.013
25. MUEHLBERG FL, SONG YH, KROHN A, PINILLA SP, DROLL LH et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009; 30: 589-597. doi:10.1093/carcin/bgp036
26. MARTIN FT, DWYER RM, KELLY J, KHAN S, MURPHY JM et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010; 124: 317-326. doi:10.1007/s10549-010-0734-1
27. HUNAKOVA L, SEDLAKOVA O, CHOLUJOVA D, GRONESOVA P, DURAJ J, SEDLAK J. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma 2009; 56: 548-556. doi:10.4149/neo_2009_06_548
28. LI W, WEI Z, LIU Y, LI H, REN R, TANG Y. Increased 18FFDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-beta. Neoplasma 2010; 57: 234-240. doi:10.4149/neo_2010_03_234
29. LAZENNEC G, RICHMOND A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010; 16: 133-144. doi:10.1016/j.molmed.2010.01.003
30. KHAKOO AY, PATI S, ANDERSON SA, REID W, ELSHAL MF et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006; 203: 1235-1247.
31. NAKAMURA K, ITO Y, KAWANO Y, KUROZUMI K, KOBUNE M et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155-1164. doi:10.1038/sj.gt.3302276
32. OHLSSON LB, VARAS L, KJELLMAN C, EDVARDSEN K, LINDVALL M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 2003; 75: 248-255. doi:10.1016/j.yexmp.2003.06.001
33. QIAO L, XU ZL, ZHAO TJ, YE LH, ZHANG XD. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008; 269: 67-77. doi:10.1016/j.canlet.2008.04.032
34. SPEAR SL, WILSON HB, LOCKWOOD MD. Fat injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg 2005; 116: 1300-1305. doi:10.1097/01.prs.0000181509.67319.cf
35. SAPHNER T, TORMEY DC, GRAY R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996; 14: 2738-2746.
36. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-1717. doi:10.1016/ S0140-6736(05)66544-0
37. HEDLEY BD, CHAMBERS AF. Tumor dormancy and metastasis. Adv Cancer Res 2009; 102: 67-101. doi:10.1016/S0065-230X(09)02003-X
38. HU M, POLYAK K. Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 2008; 44: 2760-2765. doi:10.1016/j.ejca.2008.09.038
39. KUCEROVA L, MATUSKOVA M, HLUBINOVA K, ALTANEROVA V, ALTANER C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010; 9: 129. doi:10.1186/1476-4598-9-129
40. KUCEROVA L, ALTANEROVA V, MATUSKOVA M, TYCIAKOVA S, ALTANER C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304-6313. doi:10.1158/0008-5472.CAN-06-4024
41. MATUSKOVA M, HLUBINOVA K, PASTORAKOVA A, HUNAKOVA L, ALTANEROVA V et al, HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Let, 2010; 290: 58-67. doi:10.1016/j.canlet.2009.08.028
42. ABOODY KS, NAJBAUER J, SCHMIDT NO, YANG W, WU JK et al. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 2006; 8: 119-126. doi:10.1215/15228517-2005-012
43. LAZENNEC, G. AND C. JORGENSEN, Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells, 2008. 26: p. 1387-94. doi:10.1634/stemcells.2007-006
44. ALTANEROVA V, HORVATHOVA E, MATUSKOVA M, KUCEROVA L, ALTANER C. Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation. Neoplasma 2009; 56: 542-547. doi:10.4149/neo_2009_06_542
45. KARNOUB AE, DASH AB, VO AP, SULLIVAN A, BROOKS MW et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563. doi:10.1038/nature06188
46. FIERRO FA, SIERRALTA WD, EPUÑAN MJ, MINGUELL JJ. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 2004; 21: 313-319. doi:10.1023/B:CLIN.0000046130.79363.33
47. RHODES LV, ANTOON JW, MUIR SE, ELLIOTT S, BECKMAN BS, BUROW ME. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Mol Cancer 2010; 9: 295. doi:10.1186/1476-4598-9-295
48. BURGER JA, KIPPS TJ CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-1767. doi:10.1182/blood-2005-08-3182
49. ORIMO A, GUPTA PB, Sgroi DC, Arenzana-Seisdedos F, DELAUNAY T et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348. doi:10.1016/j.cell.2005.02.034
50. KOJIMA Y, ACAR A, EATON EN, MELLODY KT, SCHEEL C et al. Autocrine TGF-beta and stromal cellderived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA 2010; 107: 20009-20014. doi:10.1073/pnas.1013805107
51. CHENG N, CHYTIL A, SHYR Y, JOLY A, MOSES HL. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis. Cancer Res 2007; 67: 4869-7487. doi:10.1158/0008-5472.CAN-06-3381